BEGIN:VCALENDAR VERSION:2.0 PRODID:-//wp-events-plugin.com//7.2.3.1//EN TZID:America/Phoenix X-WR-TIMEZONE:America/Phoenix BEGIN:VEVENT UID:1677@azbio.org DTSTART;TZID=America/Phoenix:20220816T080000 DTEND;TZID=America/Phoenix:20220816T090000 DTSTAMP:20220603T215305Z URL:https://www.azbio.org/events/azbiopeers-youve-found-lab-space-now-what -setting-up-a-clia-lab SUMMARY:AZBioPEERS: Business Basics Series- How To Build An Investable Team - - 16 Aug 22 08:00 DESCRIPTION:\nBusiness Basics Series- How To Build An Investable Team\nTues day\, August 16th\, 2022   08:00 – 09:00 AM\n\nFeatured Speakers:\n\n David Youngentob- Director\, Willamette Valley Capital (https://willamette .vc)\n Mara Aspinall- Managing Director\, Bluestone Venture Partners\n J ames Goulka- Managing Director\, Arizona Tech Investors (ATI).\n\nVCs and Angels often say the number one thing they look for in a company is a stro ng team. Please join us for a discussion of how to build a team that attra cts investors for your company. \n\n \;\n\nLocation:  Virtual via Zo om\n\n \;\nREGISTER\nAbout Our Speakers\n \;\nDavid Youngentob – Director\, Willamette Valley Capital\nDavid is a finance &\; investmen t professional with experience spanning the management of $5B of technolog y development capital for Intel Corporation\, $10M of venture fundraising across biotech\, and technology businesses\, and four years of experience at WVC sourcing and screening deals\, leading diligence efforts\, and se rving as board observer to portfolio companies. David is also co-founder a nd Portfolio Manager of Greyhound Asset Management\, LLC\, a private inves tment fund centered in liquid securities exposure to connected world techn ologies and disruptive innovation firms. Strategist\, opportunist\, relati onship builder\, focused communicator\, and systems thinker with natural a nd formally trained analytic skills in science\, business\, and finance.\n \nDavid earned a Biotechnology B.S.\, cum laude from SUNY College of Envir onmental Science and Forestry\; Molecular Biology M.S. and Finance MBA fro m University of Oregon\, and membership in Beta Gamma Sigma honors society .\n\n \;\n\n\n\nMara Aspinall- Managing Director\, Bluestone Venture P artners\n\n\n\n\n\n\n\nMara Aspinall is a healthcare industry leader and p ioneer with a commitment to active civic involvement. Aspinall is Co-Found er and Managing Director of BlueStone Venture Partners.  Aspinall also he ads the Health Catalysts Group publishing the popular Health Catalysts Dia gnostics Year in Review. Aspinall is an advisor to The Rockefeller Foundat ion on COVID diagnostics.\n\nAspinall is passionate about education on dia gnostics\, genomics\, and personalized medicine. To that end\, Mara co-fou nded the School of Biomedical Diagnostics at Arizona State University\, th e first school dedicated to Diagnostics as an independent discipline.\n\nA spinall served as President and CEO of Ventana Medical Systems\, now Roche Tissue Diagnostics\, a $1 billion division of the Roche Group. Previously \, she was President of Genzyme Genetics and Genzyme Pharmaceuticals.  De eply committed to expanding learning\, Aspinall was an active member of th e US Health and Human Services Secretary’s Advisory Council on Genetics\ , Health &\; Society (SACGHS) in the Obama and Bush administrations. As pinall is also certified in Cybersecurity Oversight from Carnegie Mellon U niversity.\n\nMara was named Arizona Biosciences Leader of the Year by the Arizona Bio Association and one of “100 Most Inspiring People in Life S ciences” by PharmaVOICE and one of Women Inc.’s Most Influential Corpo rate Board Directors. Ms. Aspinall holds an MBA from Harvard Business Scho ol and a BA from Tufts University.  She is a member of the Board of Direc tors of several publicly traded companies including Abcam plc\, Allscripts \, Castle Biosciences\, DA32\, OraSure\, and Blue Cross Blue Shield Arizon a. She also is a Board Member for Pyx Health and is a Board Observer for G T Medical Technologies.\n\n\n \;\nJames Goulka- Managing Director\, Ar izona Tech Investors (ATI).\nATI is comprised of about 90 men and women wh o invest their own resources in disruptive startups in information technol ogy and life sciences. Since its inception in 2007\, ATI members have inve sted\, directly\, through entities and through three funds\, in 56 compani es\, 46 of which are Arizona-based.\n\nGoulka previously served as CEO of software companies NetSelector Inc (sold to Apple\, Inc)\, Jump-Start Solu tions\, and bid4real.com. Additionally\, he was CEO of the National Techno logy Transfer Center\, which commercialized IP developed in all 10 NASA la bs and parts of the Department of Defense\; the Frank Lloyd Wright Foundat ion\, the Frank Lloyd Wright School of Architecture\, and Taliesin Preserv ation\, Inc.\; and served as COO and CFO of Encyclopaedia Britannica Inc. and its world-wide subsidiaries. At Britannica\, Goulka was responsible fo r digitizing the product line. Goulka began his career in corporate financ e and private equity at JP Morgan Chase and Citibank.\n\nGoulka is a gover ning or advisory board member of several ATI portfolio companies. Previous ly he was Chairman of Merriam-Webster Dictionaries and most of Britannica ’s world-wide subsidiaries\, and a board member of various early stage c ompanies. His not-for-profit board involvement included Steppenwolf Theate r Company\, Chicago Shakespeare\, the Dallas Zoological Society\, and the Associate Board of the Cox School of Business at Southern Methodist Univer sity\, as well as multiple social service boards. He has also served on el ected school and township boards.\n\nGoulka holds two degrees from Yale.\n \n\n CATEGORIES:AZ - Central END:VEVENT BEGIN:VTIMEZONE TZID:America/Phoenix X-LIC-LOCATION:America/Phoenix BEGIN:STANDARD DTSTART:20210816T080000 TZOFFSETFROM:-0700 TZOFFSETTO:-0700 TZNAME:MST END:STANDARD END:VTIMEZONE END:VCALENDAR